Skip to content

Calibration and Validation of the Masimo Temperature Device in Febrile Patients

Calibration and Validation of the Masimo Rad-G With Temperature Device in Febrile Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05674344
Enrollment
170
Registered
2023-01-06
Start date
2022-12-01
Completion date
2023-03-02
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever

Brief summary

The goal of this clinical trial is to test the performance of the Masimo noninvasive temperature device in patients with fever. The main question it aims to answer is whether the Masimo temperature device is comparable to standard methods of taking temperature such as inserting a probe under the tongue or using a forehead thermometer. Participants will be asked to sit still while rounds of measurements are taken using the Masimo temperature device and the reference temperature device. Researchers will compare the measurements taken with the Masimo device with the measurements taken with the reference device.

Detailed description

Individual sites are only representative of a subset of the overall population, per ISO 80601-2-56:2017(Medical electrical equipment - Part 2-56: Particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement), and therefore clinical bias and limits of agreement should not be evaluated for the subsets. Publication of results should include repeatability from individual sites and the combined clinical bias and limits of agreement (NCT05787782, NCT05674344, and NCT05779397)

Interventions

DEVICEMasimo Temperature device

Non-invasive temperature device

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age ≥ 1year old * Febrile at time of enrollment: ≥ 99.5oF/37.5oC for patients ages 1-5 years; ≥ 100.4oF/38oC for patients older than 5 years old. * English- or Spanish-speaking patient or parent/LAR

Exclusion criteria

* Patients deemed not suitable for the study at the discretion of the investigator * Patients who are rated as a 1 or 2 Emergency Severity Index

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Masimo RAD-GT Temperature Measurments15-30 MinutesThe accuracy of the Masimo Rad-GT sensor will be determined by calculating the clinical bias (Δcb), limits of agreement (LA), and repeatability (σr). The temperature measurements from Masimo Rad-GT will be compared to the reference temperature measurements (degrees Celsius).

Countries

United States

Participant flow

Participants by arm

ArmCount
Masimo Noninvasive Temperature Device
All subjects who qualify for the trial and participate in data collection will have temperature taken using the Masimo noninvasive temperature device and the reference temperature device. Masimo Temperature device: Non-invasive temperature device
170
Total170

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyIncomplete study procedures3
Overall StudyScreen Fail21

Baseline characteristics

CharacteristicMasimo Noninvasive Temperature Device
Age, Categorical
<=18 years
170 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
126 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
41 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
12 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
65 Participants
Race (NIH/OMB)
White
92 Participants
Region of Enrollment
United States
170 participants
Sex: Female, Male
Female
90 Participants
Sex: Female, Male
Male
80 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 170
other
Total, other adverse events
0 / 170
serious
Total, serious adverse events
0 / 170

Outcome results

Primary

Accuracy of Masimo RAD-GT Temperature Measurments

The accuracy of the Masimo Rad-GT sensor will be determined by calculating the clinical bias (Δcb), limits of agreement (LA), and repeatability (σr). The temperature measurements from Masimo Rad-GT will be compared to the reference temperature measurements (degrees Celsius).

Time frame: 15-30 Minutes

Population: Subject 1 to 91 were part of the calibration phase of the study (91 subjects) and data was excluded from analysis.~14 excluded due to screen fails.~Subject 92 to 170 (79 subjects) were part of the validation phase of the study. 10 screen fails. 4: Any subject who does not complete at least one full round of measurements. 26: Any subject whose data suggests existence of external conditions that interfere with RCT (reference clinical thermometer) or Rad-GT measurements.

ArmMeasureGroupValue (NUMBER)
Masimo Noninvasive Temperature DeviceAccuracy of Masimo RAD-GT Temperature MeasurmentsClinical Bias-0.24 Degrees Celsius
Masimo Noninvasive Temperature DeviceAccuracy of Masimo RAD-GT Temperature MeasurmentsLimits of Agreement0.85 Degrees Celsius
Masimo Noninvasive Temperature DeviceAccuracy of Masimo RAD-GT Temperature MeasurmentsRepeatability0.09 Degrees Celsius

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026